CTVA
Overvalued by 32.6% based on the discounted cash flow analysis.
Market cap | $40.31 Billion |
---|---|
Enterprise Value | $43.29 Billion |
Dividend Yield | $0.6271 (1.08%) |
Earnings per Share | $0.79 |
Beta | 0.82 |
Outstanding Shares | 696,976,000 |
Avg 30 Day Volume | 3,104,817 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 72.1 |
---|---|
PEG | -243.76 |
Price to Sales | 2.4 |
Price to Book Ratio | 1.64 |
Enterprise Value to Revenue | 2.57 |
Enterprise Value to EBIT | 22.65 |
Enterprise Value to Net Income | 77 |
Total Debt to Enterprise | 0.11 |
Debt to Equity | 0.19 |
No data
No data
Corteva Agriscience is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry - including a balanced and diverse mix of seed, crop protection and di...